Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp)

Pain is known to reduce hemodialysis treatment adherence, reduce quality of life, and increase mortality. The absence of effective strategies to treat pain without medications has contributed to poor health outcomes for people with end-stage kidney disease (ESKD) on hemodialysis. It is now recognize...

Descripción completa

Detalles Bibliográficos
Autores principales: Lockwood, Mark B., Fischer, Michael J., Silva, Kimberly, Contreras, Blanca N., Zamora, Guillermo, Goldstein, Amanda, Meinel, Monya, Holden, Christopher, Lash, James, Steffens, Alana, Doorenbos, Ardith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464895/
https://www.ncbi.nlm.nih.gov/pubmed/36105265
http://dx.doi.org/10.1016/j.conctc.2022.100995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464895/
https://www.ncbi.nlm.nih.gov/pubmed/36105265
http://dx.doi.org/10.1016/j.conctc.2022.100995

Ejemplares similares